Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Johnson; Dale E.
Address:
Emeryville, CA
No. of patents:
6
Patents:












Patent Number Title Of Patent Date Issued
8017116 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis September 13, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7897148 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis March 1, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7879987 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis February 1, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7776585 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis August 17, 2010
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7285268 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis October 23, 2007
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7276589 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis October 2, 2007
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of










 
 
  Recently Added Patents
Targeting agents for enhancing radiation therapy
Detachably integrated battery charger for mobile cell phones and like devices
Display apparatus
Method and system for placing an emergency call
Fishing apparatus
Simplified algorithm for abnormal situation prevention in load following applications including plugged line diagnostics in a dynamic process
Application authentication system and method
  Randomly Featured Patents
Geospatial modeling system providing geospatial model data target point filtering based upon radial line segments and related methods
Anode support member
Circular magnetic target for an electronic article surveillance system
Geographical surveying using multiple cameras to obtain split-screen images with overlaid geographical coordinates
Apparatus and method for cutting using a liquid fluid jet
Resonant vibrating structures with driving sensing means for noncontacting position and pick up sensing
Distortion compensating device
Cancer vaccine based on brother of regulator of imprinted sites molecule
Apparatus and method for detecting and handling exceptions
Herbicidal imidazolidinetrione and thioxo-imidazolidinediones